Dolat Capital: Syngene International - Operationally Weak Q2, Expect Traction In H2 FY21 
Syngene International Biology facility (Image: Company website)

Dolat Capital: Syngene International - Operationally Weak Q2, Expect Traction In H2 FY21 

BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer Bl...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.